Several researchers have reported that the overexpression of CDC20 is associated with prognosis in bladder cancer,47 hepatocellular carcinoma,28 and triple-negative breast cancer48 and exerts different effects on different tumor types. This evidence concerns the gene CDC20 and neoplasm.